clinical trials

School of Medicine to serve as lead site for clinical trial on stuttering

Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.

By Iqbal Pittalwala | December 15, 2020 | Health

Ecopipam reduces stuttering symptoms in proof-of-concept trial

UC Riverside-led open-label pilot study leads to a double-blind clinical trial to further test ecopipam’s efficacy and safety in adult patients who stutter

By Iqbal Pittalwala | August 28, 2019 | Health

Hope on the horizon for treating stroke

UC Riverside biomedical scientist’s decades-long work moves to clinical trials

By Iqbal Pittalwala | May 9, 2019 | Health

News

University of California, Riverside